Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 427
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05414097 | Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa | ||
| NCT03907657 | Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau | ||
| NCT05722847 | Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer | ||
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | ||
| NCT00246753 | Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT01305941 | A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases | ||
| NCT00448201 | Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease | ||
| NCT00405366 | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer | ||
| NCT03442569 | PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC | ||
| NCT00499395 | Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer | ||
| NCT00719173 | Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer | ||
| NCT04271254 | PET/MR Characterization of Renal Cell Carcinomas | ||
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | ||
| NCT03546556 | 18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients | ||
| NCT04021238 | Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging | ||
| NCT00486304 | Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy | ||
| NCT01702844 | Single Arm on the Tolerability of Weekly Nab-paclitaxel | ||
| NCT05413811 | Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV | ||
| NCT07463833 | Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology | ||
| NCT06296368 | DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics | ||
| NCT04432753 | Effect of Incidental Findings Information on Lung Cancer Screening Intent | ||
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback | ||
| NCT03196037 | Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors | ||
| NCT03424837 | A Survivorship Care Plan and Embedded Navigation Tool | ||
| NCT03597009 | A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion | ||
| NCT01845519 | Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors | ||
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | ||
| NCT06547034 | VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects | ||
| NCT02306252 | The CARE Program: CAncer REhabilitation Pilot Study for Older Adults | ||
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | ||
| NCT03076333 | PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas | ||
| NCT06902376 | XL092 and Cemiplimab in BRAF WT Thyroid Cancer | ||
| NCT01776138 | Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer | ||
| NCT03156244 | Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients | ||
| NCT04570709 | RN-Led Palliative and Supportive Care Intervention | ||
| NCT03899441 | Multimedia Aid Gynecologic Counseling and Consent | ||
| NCT02246907 | Exercise and Quality of Life in Leukemia Patients | ||
| NCT07582536 | Optimization of Dietary Adherence in a Mobile Weight Loss Intervention | ||
| NCT00776126 | Digital Breast Tomosynthesis Preference Study | ||
| NCT05574478 | Metastatic Breast Cancer-Specific Prognostic Tool | ||
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT01655745 | Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | ||
| NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC | ||
| NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
| NCT06263582 | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | ||
| NCT05483023 | 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy | ||
| NCT03717844 | Registry for Adults With Plasma Cell Disorders (PCD's) | ||
| NCT01488487 | Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma | ||
| NCT03160209 | HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi | ||
| NCT03454035 | Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
